Curetis Announces Positive Top Line Data from U.S. FDA Trial
Curetis N.V. (the "Company" and, together with Curetis GmbH, "Curetis"), a developer of next-level molecular diagnostic…
Curetis N.V. (the "Company" and, together with Curetis GmbH, "Curetis"), a developer of next-level molecular diagnostic…
. - Diagnostic workflow for C. difficile is launched in Europe and submitted in the U.S. for 510(k) clearance as the fi…
. - Baseline and biomarker characteristics of advanced HCC patients identified that have an impact on overall survival…
Roche today announced the global launch of new software updates, including advanced high- resolution melting analysis an…
. - U.S. submission of therascreen® EGFR RGQ PCR Kit is paired with FDA submission of afatinib, an investigational tyro…
Today Roche announced the global launch of its new LightCycler 96 System, which completes its portfolio of Real Time PCR…
Today Roche announced the global launch of its new High Pure FFPET RNA Isolation Kit as well as the RealTime ready cDNA…
geneOnyx(TM) , a provider of over-the-counter cloud based genetic analytics services for cosmetics and skincare applicat…
MAB Discovery, a provider of exceptional therapeutic monoclonal antibodies, announced today that they have initiated two…
. - U.S. launch of therascreen® KRAS RGQ PCR Kit offers enhanced approach to guide treatments for approximately 110,000…